期刊文献+

匹多莫德口服液中有关物质的HPLC法测定 被引量:4

Determination of Related Substances of Pidotimod Oral Solution by HPLC
原文传递
导出
摘要 根据匹多莫德有关物质极性大小及立体结构差异,建立了4种高效液相色谱条件分别测定匹多莫德口服液的9个有关物质及降解产物。结果,在相应色谱条件下,各有关物质和降解产物与匹多莫德、其他杂质及辅料分离完全,方法回收率为94.1%~102.6%,RSD为0.64%~2.11%。 Four determination conditions of HPLC were established based on the polarities and the stereo structures of nine specific related substances and degradation products of pidotimod oral solution. The results showed that the specific related substances and degradation products could be fully separated from pidotimod, other impurities and the excipients under the corresponding chromatographic conditions. The recoveries were 94.1%-102.6 %, with RSDs of 0.64%-2.11%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2016年第12期1568-1573,共6页 Chinese Journal of Pharmaceuticals
关键词 匹多莫德 有关物质 高效液相色谱法 含量测定 pidotimod related substance HPLC content determination
  • 相关文献

参考文献6

二级参考文献59

  • 1田新平,曾小峰.新型合成免疫调节剂——匹多莫德[J].中国新药杂志,2005,14(1):111-114. 被引量:97
  • 2李秀珍,王赟,商志才,俞庆森.免疫促进剂匹多莫德的合成改进[J].化学世界,2005,46(9):555-557. 被引量:5
  • 3李一平,蔡辉,顾远晖,李渊.匹多莫德对慢性丙型肝炎患者免疫功能的影响[J].兰州大学学报(医学版),2006,32(1):33-34. 被引量:3
  • 4Flouret G. Synthesis of pyroglutamylhistidylprolineamide by classical and solid phase methods [J], J Med Chem, 1970, 13 (5) : 843-845.
  • 5Poli S, Del Corona L. Process for the preparation of 3- (ipyroglutamyl) -L-thiazolidine-4-carboxylic acid derivatives: US, 5110936 [P]. 1992-05-05.
  • 6Poli S. Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it: US, 4839387 [P]. 1989-06-13.
  • 7Rather S, Clarke HT. The action of formaldehyde upon cysteine [J]. JAm Chem Soc, 1937, 59 (1): 200-206.
  • 8Haskell TH, Hutt MP. Antibacterial amide compounds, compositions thereof and methods of using them: US, 4382089 [P]. 1983-05-03.
  • 9中国药典[S].2010年版.二部.附录ⅨJ.
  • 10谭焕然 董茜 曹立珍.匹多莫德的免疫增强作用及对淋巴因子表达的影响[J].北京医科大学学报,1999,31(2):38-41.

共引文献143

同被引文献15

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部